Fact sheet: UBS (L)E-HlthCre$

Fund information
Fund name
UBS (Lux) Equity - Health Care (USD) P Acc
Fund manager company
UBS AG
Fund type
No data available.
Fund managers
  • Scott Wilkinsince 31/08/2016
  • Matthew Konoskysince 31/08/2016
Fund objective
Actively managed equity portfolio investing worldwide in companies from the healthcare sector. Efficient means of exploiting the potential of companies operating in the healthcare sector. Specialised sector analysts seek out the most attractive stocks in the healthcare sector worldwide. Investment decisions are based on a disciplined investment philosophy and fundamental research.
Benchmark
  • MSCI World Health Care Index
Investment style
None
Investment method
Shares
Quick stats
1 Year return
9.9%
1 Year rank in sector
13/29
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
2.11%
Fund size
£192m (£173m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
131
Top in this sector
Fund name1 Year
Pictet Biotech22.5%
Polar Capital Biotechnology21.4%
Fidelity Gbl Health Care19%
Variopartner SICAV MVGbMdtcF18%
Pictet Health16.6%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • USA72.7%
    Germany5.8%
    Japan5.1%
    Switzerland5%
    UK3.6%
  • Pharmaceuticals63.3%
    Biotechnology/Medical16.5%
    Health Care11.8%
    Financials4.4%
    Engineering & Machinery2.4%
  • US Equities72.7%
    German Equities5.8%
    Japanese Equities5.1%
    Swiss Equities5%
    UK Equities3.6%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund2%3.3%12.2%9.9%22.6%104%
Sector1%1.1%7.3%11%30.3%107.8%
Rank within sector8 / 307 / 294 / 2913 / 2918 / 2615 / 23
Quartile2nd1st1st2nd3rd3rd
Calendar performance
 YTD - 20172016201520142013
Fund11.3%-7.8%9.2%20.5%34.9%
Sector10%-9.9%7.2%28.1%41%
Rank within sector12 / 2910 / 2913 / 2721 / 2414 / 23
Quartile2nd2nd2nd4th3rd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
-1.08
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.8
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.26
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
13.47
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
6.14
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
-0.47
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.85
Price movement
52 week high250.13
52 week low214.35
Current bid price-
Current offer price-
Current mid price249.1
Region
1USA72.66%
2Germany5.81%
3Japan5.11%
4Switzerland4.96%
5UK3.58%
6France3.56%
7Denmark2.64%
8Others0.72%
9Hungary0.53%
Industry sector
1Pharmaceuticals63.32%
2Biotechnology/Medical16.46%
3Health Care11.84%
4Financials4.39%
5Engineering & Machinery2.39%
6Other Industrials1.25%
7Mutual Funds0.34%
8Others0%
Asset type
1US Equities72.66%
2German Equities5.81%
3Japanese Equities5.11%
4Swiss Equities4.96%
5UK Equities3.58%
6French Equities3.56%
7Danish Equities2.64%
8International Equities0.72%
9Hungarian Equities0.53%
Individual holdings
1UNITEDHEALTH GROUP INC6.06%
2JOHNSON & JOHNSON5.99%
3LILLY (ELI) & CO5.3%
4MERCK & CO INC(NEW)4.73%
5ALLERGAN PLC4.52%
6ABBOTT LABORATORIES4.16%
7CELGENE CORP4.13%
8SHIRE PLC3.57%
9SANOFI3.55%
Management
Fund manager group
UBS
Fund manager company
UBS AG
Fund type
No data available.
Fund objective
Actively managed equity portfolio investing worldwide in companies from the healthcare sector. Efficient means of exploiting the potential of companies operating in the healthcare sector. Specialised sector analysts seek out the most attractive stocks in the healthcare sector worldwide. Investment decisions are based on a disciplined investment philosophy and fundamental research.
Benchmark
  • MSCI World Health Care Index
Investment style
None
Investment method
Shares
Fund managers
NameSinceBiography
Scott Wilkin31/08/2016
Matthew Konosky31/08/2016
Compliance
Transparent for Austrian Tax, Transparent for Swiss Tax, Transparent for German Tax, UCITS IV Compliant
Domicile
No data available.
Fund for sale in
Austria, Switzerland, Chile, Cayman Islands, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Italy, Japan, Republic Of Korea, Liechtenstein, Luxembourg, Netherlands, Norway, Offshore, Peru, Portugal, Singapore, Sweden, Taiwan - Province Of China
UBS (Lux) Equity - Health Care (USD) P Acc
Initial charge2%
Annual charge1.63%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)2.11%
Total expense ratio (TER)2.1%
Bid price-
Offer price-
Mid price249.1
CurrencyUSD
Price updated23/05/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeUB44
UBS (Lux) Equity - Health Care (USD) Q Acc
Initial charge2%
Annual charge0.82%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.09%
Total expense ratio (TER)1.09%
Bid price-
Offer price-
Mid price145.72
CurrencyUSD
Price updated23/05/2017
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeFDRM
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.